³í¹®) A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13) ¿¬¼¼¾Ïº´¿ø Á¾¾ç³»°ú ±è±ÔÇö‧Á¤¹Î±Ô‧½Å»óÁØ ±³¼ö ¿¬±¸ÆÀ